Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
December 13, 2019

3M to sell drug delivery business to Altaris Capital Partners in $650m deal

3M, a US-based manufacturing company, has agreed to sell almost all of its drug delivery business to an affiliate of Altaris Capital Partners for about $650m.

Continue
Altaris Capital Partners to by almost all the drug delivery business of 3M. Photo: courtesy of Steve Buissinne from Pixabay.
December 12, 2019

Leo Pharma’s tralokinumab meets key endpoints in phase 3 atopic dermatitis trials

Image: Atopic dermatitis of the inside crease of the elbow. Photo: courtesy of James Heilman, MD.
December 11, 2019

Dermira secures FDA fast track status for lebrikizumab in atopic dermatitis

FDA grants fast track designation to lebrikizumab in atopic dermatitis. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org.

Contracts

November 22, 2019

ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment

Image: ViiV Healthcare to develop investigational bNAbs. Photo: Courtesy of GlaxoSmithKline plc.

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

GeoVax, Leidos expand collaboration to malaria vaccines

Deals

Deals December 11, 2019

Amneal to buy generic pharmaceuticals provider AvKAR for $340m

Pharmaceutical Business Review

Sanofi to acquire Synthorx for $2.5bn to strengthen immuno-oncology pipeline

Merck to buy biopharmaceutical firm ArQule for $2.7bn

XBiotech to sell anti- IL-1⍺ antibody bermekimab to Janssen in $1.3bn deal

Popular

  1. Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH
  2. Celsius Therapeutics signs collaboration agreement with Janssen to identify response biomarkers for ulcerative colitis
  3. Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
  4. VALBIOTIS announces positive results from phase IIA trial of VALEDIA in prediabetics
  5. GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis

PRESS RELEASES

German Health Authorities Grant LTS the Manufacturer’s Authorisation for Capsules
German Health Authorities Grant LTS the Manufacturer’s Authorisation for Capsules
7PSolutions Joins Forces with Eye-Seal’s Smart Internal Container Breach Detection Technology
7PSolutions Joins Forces with Eye-Seal’s Smart Internal Container Breach Detection Technology
30 Years One-Stop-Shop for Protein Purification and Analysis
30 Years One-Stop-Shop for Protein Purification and Analysis
Optibrium Collaborates with Enamine and BioSolveIT to Add REAL Space Search Tool to StarDrop
Optibrium Collaborates with Enamine and BioSolveIT to Add REAL Space Search Tool to StarDrop
Black Friday Special Training Offers from NSF
Black Friday Special Training Offers from NSF

Suppliers

Whitepapers

About the World’s First Ph. Eur. 5.24 Compliant FTIR Imaging by FPA and PermaSure+
About the World’s First Ph. Eur. 5.24 Compliant FTIR Imaging by FPA and PermaSure+
Documentation Complexity at Crisis Point?
Documentation Complexity at Crisis Point?
Oxetanes
Oxetanes